Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells Health and Family Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells Karren Franco 3 June، 2025 WALTHAM, Mass. Minerva Biotechnologies published “Effective CAR T cell targeting of a MUC1 cleavage product” in the... Read More Read more about Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells
